unknown
Stage
2
Investors
About
Evozyne is a biotechnology company that uses generative AI combined with high-throughput biology to design and build engineered therapeutic proteins. The company focuses on creating novel protein therapeutics for immune-mediated diseases.
Explore Evozyne's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.